Colistimethate sodium injection - GlaxoSmithKline

Drug Profile

Colistimethate sodium injection - GlaxoSmithKline

Alternative Names: Aldreb; Colistimethate sodium - GlaxoSmithKline

Latest Information Update: 23 Jan 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antibacterials; Polymixins
  • Mechanism of Action Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Bacterial infections

Most Recent Events

  • 03 Nov 2015 Launched for Bacterial infections in Japan (Infusion)
  • 26 Mar 2015 Registered for Bacterial infections in Japan (Infusion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top